z-logo
open-access-imgOpen Access
Could ketoconazole predict the response of abiraterone in patients with metastatic castration-resistant prostate cancer (crpc) pre-treated with docetaxel
Author(s) -
Bo-Han Chen,
Chung-Cheng Kao,
TaiLung Cha,
Guang-Haun Sun,
DahShyong Yü,
SunYran Chang,
Seng-Tang Wu
Publication year - 2015
Publication title -
urological science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.155
H-Index - 8
eISSN - 1879-5234
pISSN - 1879-5226
DOI - 10.1016/j.urols.2015.06.063
Subject(s) - docetaxel , medicine , ketoconazole , abiraterone , prostate cancer , cabazitaxel , oncology , cancer , androgen deprivation therapy , dermatology , androgen receptor , antifungal

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here